Goldman Sachs’s Azora Therapeutics AZR Stock Holding History
Bought
Maintained
Sold
Other funds holding AZR
Goldman Sachs's AZR Position: Q1 2022 in Review
Goldman Sachs sold out of Azora Therapeutics (AZR) in Q1 2022, closing a stake of 31 shares — an estimated $53K sold.
Goldman Sachs first reported a position in AZR in Q4 2021 and held it in 1 quarter. The position peaked at $53K in Q4 2021. 23 funds tracked by Wall St. Rank hold AZR as of Q1 2022.
- Goldman Sachs reported no remaining Azora Therapeutics position as of Q1 2022 after selling out during the quarter.
- Goldman Sachs sold 31 Azora Therapeutics shares in Q1 2022, an estimated $53K.
- Goldman Sachs first reported a position in Azora Therapeutics in Q4 2021 and held it in 1 quarter.
- Goldman Sachs's Azora Therapeutics position peaked at $53K in Q4 2021.
- 23 funds tracked by Wall St. Rank held Azora Therapeutics as of Q1 2022.
Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.